During the past decade, Athens General Hospital 'G Gennimatas conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Athens General Hospital 'G Gennimatas" #1 sponsor was "G.Gennimatas General Hospital" with 4 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Protagonist Therapeutics, Inc." with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Athens General Hospital 'G Gennimatas" #1 collaborator was "Academy of Athens" with 1 trials as a collaborator, "Evangelismos Hospital" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Athens General Hospital 'G Gennimatas" are "Acute Myocardial Infarction" (2 trials), "Anemia" (2 trials), "Atrial Fibrillation" (2 trials), "Ineffective Erythropoiesis" (2 trials) and "β-thalassemia" (2 trials). Many other conditions were trialed in "Athens General Hospital 'G Gennimatas" in a lesser frequency.

Most popular intervention types in "Athens General Hospital 'G Gennimatas" are "Drug" (11 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Colchicine" (2 trials), "PTG-300" (2 trials), "Tirzepatide" (2 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Athens General Hospital 'G Gennimatas" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Athens General Hospital 'G Gennimatas". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Athens General Hospital 'G Gennimatas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Athens General Hospital 'G Gennimatas, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".